| Myeloproliferative Neoplasms (MPNs) Patient Registry (NCT02760238) | University Health Network, Toronto | 2015-04-01 |
| Italian Network MDS Registry (NCT02808858) | Fondazione Italiana Sindromi Mielodisplastiche-ETS | 2013-09-01 |
| Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases (NCT00813501) | City of Hope Medical Center | 2008-06-01 |
| Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00555048) | Fred Hutchinson Cancer Center | 2007-09-01 |
| Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer (NCT00787761) | Northside Hospital, Inc. | 2007-04-01 |
| Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT00425477) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-11-01 |
| Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant (NCT00410657) | Fred Hutchinson Cancer Center | 2006-07-01 |
| Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer (NCT00346359) | Fred Hutchinson Cancer Center | 2006-03-01 |
| Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant (NCT00281814) | The Cleveland Clinic | 2006-02-01 |
| Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation (NCT00281801) | Case Comprehensive Cancer Center | 2006-02-01 |
| Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders (NCT00293410) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-11-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease (NCT00719849) | Fred Hutchinson Cancer Center | 2005-11-01 |
| Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder (NCT00274820) | Case Comprehensive Cancer Center | 2005-10-01 |
| Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer (NCT00611351) | University of Nebraska | 2005-06-07 |
| Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer (NCT00818961) | Northside Hospital, Inc. | 2005-05-01 |
| Campath-1H + FK506 and Methylprednisolone for GVHD (NCT00109993) | Case Comprehensive Cancer Center | 2005-01-01 |
| Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00096096) | Fred Hutchinson Cancer Center | 2004-08-01 |
| Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes (NCT00093366) | Fred Hutchinson Cancer Center | 2004-06-01 |
| G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders (NCT00253552) | OHSU Knight Cancer Institute | 2004-05-01 |
| Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes (NCT00217386) | Fred Hutchinson Cancer Center | 2004-03-01 |
| 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome (NCT00077558) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-01-01 |
| Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) (NCT00075816) | Medical College of Wisconsin | 2004-01-01 |
| Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies (NCT00068523) | Case Comprehensive Cancer Center | 2003-06-01 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00062140) | Fred Hutchinson Cancer Center | 2003-04-01 |
| Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders (NCT00055653) | Roswell Park Cancer Institute | 2003-01-01 |
| Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00265837) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-12-01 |
| Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder (NCT00054340) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT00052832) | University of Wisconsin, Madison | 2002-09-01 |
| Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS (NCT00053287) | Case Comprehensive Cancer Center | 2002-09-01 |
| Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer (NCT00255710) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-07-01 |
| Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia (NCT00054236) | Case Comprehensive Cancer Center | 2002-05-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders (NCT00053989) | Roswell Park Cancer Institute | 2002-01-29 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder (NCT00049634) | Fred Hutchinson Cancer Center | 2002-01-01 |
| Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00301912) | University of California, San Francisco | 2002-01-01 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders (NCT00544115) | City of Hope Medical Center | 2001-10-16 |
| MS-275 in Treating Patients With Hematologic Cancer (NCT00015925) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2001-02-01 |
| Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer (NCT00006239) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00054327) | Case Comprehensive Cancer Center | 2000-11-01 |
| Non-Ablative Allo HSCT For Hematologic Malignancies or SAA (NCT00006379) | Case Comprehensive Cancer Center | 2000-06-01 |
| Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00004871) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-05-01 |
| Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00006042) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-12-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer (NCT00006225) | Northwestern University | 1999-11-01 |
| Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00044954) | University of Texas Southwestern Medical Center | 1999-11-01 |
| Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00004896) | Northwestern University | 1999-10-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00290628) | Masonic Cancer Center, University of Minnesota | 1999-10-01 |
| Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00004899) | Northwestern University | 1999-10-01 |
| Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome (NCT00003961) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1999-04-01 |
| Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant (NCT00530218) | City of Hope Medical Center | 1999-03-01 |
| Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease (NCT00003913) | Fred Hutchinson Cancer Center | 1998-12-01 |
| Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer (NCT00003816) | Roswell Park Cancer Institute | 1998-10-19 |
| Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer (NCT00003335) | Case Comprehensive Cancer Center | 1998-01-01 |
| Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer (NCT00003243) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-01-01 |
| Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions (NCT00003336) | Case Comprehensive Cancer Center | 1998-01-01 |
| Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders (NCT00002792) | Fred Hutchinson Cancer Center | 1996-06-01 |
| Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia (NCT00066417) | National Heart, Lung, and Blood Institute (NHLBI) | |